Livingston, NJ, United States of America

Guang-Pei Chen

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Novartis Ag, Astex Therapeutics Limited. Active years: 2004-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guang-Pei Chen. Retrieved from https://idiyas.com/inventor/guang-pei-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0


 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2004-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Guang-Pei Chen

Introduction

Guang-Pei Chen is a notable inventor based in Livingston, NJ, with a significant contribution to the field of pharmaceuticals. He holds a total of four patents, showcasing his innovative approach to drug development and formulation.

Latest Patents

His latest patents include the invention of salts of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide. This invention encompasses several key aspects: the process of making the compound and its salts, the novel salts themselves, pharmaceutical compositions that include these salts, and methods of treatment utilizing the same.

Career Highlights

Throughout his career, Guang-Pei Chen has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Astex Therapeutics Limited. His work has significantly impacted the development of new therapeutic agents.

Collaborations

Some of his notable coworkers include Prasad Koteswara Kapa and John Vincent Calienni, who have collaborated with him on various projects.

Conclusion

Guang-Pei Chen's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of new treatments and pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…